STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This study aims to compare the effectiveness of a conventional therapeutic regimen, based on
treatment escalation (step-up strategy) and driven by the treat-to-target approach, with that
of an early aggressive intervention based on the initial start of a combination of
conventional and biological DMARDs (step-down strategy).
Phase:
Phase 3
Details
Lead Sponsor:
Istituto Giannina Gaslini
Collaborators:
Agenzia Italiana del Farmaco Compagnia di San Paolo Pfizer